Financing HIV Programming: How Much Should Low- And Middle-Income Countries and their Donors Pay?

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Galárraga, Omar ^a,b   Wirtz, Veronika J ^b,c   Santa Ana Tellez, Yared ^b,d   Korenromp, Eline L ^e  

^a BROWN UNIVERSITY   (United States)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d UTRECHT UNIVERSITY   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FUNDING; HEALTH CARE COST; HEALTH CARE FINANCING; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INCOME; PREVALENCE; RESOURCE ALLOCATION; SENSITIVITY ANALYSIS; SOCIOECONOMICS;

DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; FINANCIAL SUPPORT; FINANCING, ORGANIZED; HIV INFECTIONS; HUMANS; WORLD HEALTH;

EID: 84879817799     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067565     Document Type: Article

References (46)

1. UNAIDS (2012) Together We Will End AIDS. In: UNAIDS, editor. Geneva: Joint United Nations Program on HIV/AIDS (UNAIDS); World Health Organization (WHO).
2. UNAIDS (2010) Joint Action for Results: UNAIDS Outcome Framework 2009-2011. Geneva: The Joint United Nations Program on HIV/AIDS (UNAIDS).
3. Kaiser Family Foundation (2012) Financing the Response to AIDS in Low- and Middle-Income Countries: International Assistance from Donor Governments in 2011. Washington, DC: Kaiser Family Foundation.
4. Leach-Kemon K, Chou DP, Schneider MT, Tardif A, Dieleman JL, et al. (2012) The global financial crisis has led to a slowdown in growth of funding to improve health in many developing countries. Health Aff (Millwood) 31: 228-235.
5. Kerouedan D, (2010) [The Global Fund to fight HIV/AIDS, TB and Malaria 5-y: evaluation policy issues]. Bull Soc Pathol Exot 103: 119-122.
6. Global Fund (2010) Value for money improving value for money in Global Fund-supported programs Geneva: The Global Fund to Fight AIDS, Tuberculosis and Malaria.
7. Amico P, Gobet B, Avila-Figueroa C, Aran C, De Lay P, (2012) Pattern and levels of spending allocated to HIV prevention programs in low- and middle-income countries. BMC Public Health 12: 221.
8. United Nations General Assembly (2001) Agenda item 8. In: Nations U, editor. United Nations General Assembly, Twenty-sixth special session (UNGASS). New York: United Nations.
9. Kapp C, (2002) Global Fund faces uncertain future as cash runs low. Lancet 360: 1225.
10. Burton B, (2004) Australia's contribution to global health fund provokes dismay. Bmj 328: 486.
11. Zeitz PS (2003) What is the US Fair Share of Funding Needed to Catalyze an expanded and Comprehensive Response to the Global AIDS Crisis?. In: Global AIDS Alliance, editor. International Committee, Presidential Advisory Council on HIV/AIDS. Bethesda MD.
12. Brugha R, (2005) The Global Fund at three years-flying in crowded air space. Trop Med Int Health 10: 623-626.
13. Lane C, Glassman A, (2007) Bigger and better? Scaling up and innovation in health aid. Health Aff (Millwood) 26: 935-948.
14. Global Fund (2011) Policy on eligibility criteria, counterpart financing requirements, and prioritization of proposals for funding from the Global Fund. Geneva: The Global Fund to Fight AIDS, Tuberculosis and Malaria.
15. Lu C, Schneider MT, Gubbins P, Leach-Kemon K, Jamison D, et al. (2010) Public financing of health in developing countries: a cross-national systematic analysis. Lancet 375: 1375-1387.
16. Garg CC, Evans DB, Dmytraczenko T, Izazola-Licea JA, Tangcharoensathien V, et al. (2012) Study raises questions about measurement of 'additionality,'or maintaining domestic health spending amid foreign donations. Health Aff (Millwood) 31: 417-425.
17. Savedoff WD, (2007) What should a country spend on health care? Health Aff (Millwood) 26: 962-970.
18. World Bank (2010) Country Classification Data. Washington, D.C.: World Bank.
19. World Bank (2011) Data catalog. Washington, D.C.: World Bank.
20. UNAIDS (2012) Country Reported Data for 2009 for 84 Countries.
21. WHO UNAIDS, UNICEF (2011) Global HIV/AIDS response: Epidemic update and health sector progress towards Universal Access. Progress report 2011. Geneva: World Health Organization (WHO).
22. UNAIDS (2010) The 2010 UNAIDS report on the global AIDS epidemic. Geneva: The Joint United Nations Program on HIV/AIDS (UNAIDS).
23. Schwartlander B, Stover J, Hallett T, Atun R, Avila C, et al. (2011) Towards an improved investment approach for an effective response to HIV/AIDS. Lancet 377: 2031-2041.
24. Koenker R (2005) Quantile regression. Cambridge; New York: Cambridge University Press. xv, 349 p. p.
25. Lordan G, Tang KK, Carmignani F (2011) Has HIV/AIDS displaced other health funding priorities? Evidence from a new dataset of development aid for health. Soc Sci Med 73: 351-355; discussion 356-358.
26. Andersen R (2008) Modern methods for robust regression. Los Angeles: Sage Publications. xv, 107 p. p.
27. Galárraga O, Wirtz VJ, Figueroa-Lara A, Santa-Ana-Tellez Y, Coulibaly I, et al. (2011) Unit costs for delivery of antiretroviral treatment and prevention of mother-to-child transmission of HIV: a systematic review for low- and middle-income countries. Pharmacoeconomics 29: 579-599.
28. Sachs J (2005) The end of poverty: economic possibilities for our time. New York: Penguin Press. xviii, 396 p. p.
29. Easterly W (2006) The white man's burden: why the West's efforts to aid the rest have done so much ill and so little good. Oxford; New York: Oxford University Press. 380 p. p.
30. Collier P (2007) The bottom billion: why the poorest countries are failing and what can be done about it. Oxford; New York: Oxford University Press. xiii, 205 p. p.
31. Kaplan WA, Ritz LS, Vitello M, Wirtz VJ (2012) Policies to promote use of generic medicines in low and middle income countries: A review of published literature, 2000-2010. Health Policy.
32. Wirtz VJ, Santa-Ana-Tellez Y, Trout CH, Kaplan WA (2012) Allocating scarce financial resources for HIV treatment: benchmarking prices of antiretroviral medicines in Latin America. Health Policy Plan.
33. Shadlen KC, (2012) The Mexican Exception: Patents and Innovation Policy in a Non-conformist and Reluctant Middle Income Country. European Journal of Development Research 24: 300-318.
34. Shadlen KC (2009) The Politics of Patents and Drugs in Brazil and Mexico: The Industrial Bases of Health Policies. Comparative Politics 42: 41-+.
35. Bokhari FA, Gai Y, Gottret P, (2007) Government health expenditures and health outcomes. Health Econ 16: 257-273.
36. Global Fund (2011) Decision Points of the Twenty-Fifth Board Meeting Accra, Ghana, 21-22 November 2011- Decision Point GF/B25/DP16: Modification of Grant Renewals and Transition to New Funding. Twenty-Fifth Board Meeting Accra, Ghana, 21-22 November 2011: The Global Fund to fight AIDS Tuberculosis and Malaria.
37. Saxenian H, Cornejo S, Thorien K, Hecht R, Schwalbe N, (2011) An analysis of how the GAVI alliance and low- and middle-income countries can share costs of new vaccines. Health Aff (Millwood) 30: 1122-1133.
38. WHO Commission on Macroeconomics and Health (2001) Macroeconomics and health: Investing in health for economic development World Health Organization ed. Geneva.
39. Thirumurthy H, Galarraga O, Larson B, Rosen S, (2012) HIV Treatment Produces Economic Returns Through Increased Work And Education, And Warrants Continued US Support. Health Aff (Millwood) 31: 1470-1477.
40. Hesterl V, McGreevey B, Hecht R, Avila-Figueroa C, Gaillard E (2009) Assessing costing and prioritization in National AIDS Strategic Plans. Working paper no. 26. Washington DC: Results for Development Institute.
41. United Nations Economic and Social Commission for Asia and the Pacific (2008) HIV and AIDS in Asia and the Pacific: A review of progress towards Universal Access. Discussion paper prepared for the UNESCAP/UNAIDS Expert Group Meeting. Bangkok: United Nations ESCAP.
42. Munderi P, Grosskurth H, Droti B, Ross DA, (2012) What are the essential components of HIV treatment and care services in low and middle-income countries: an overview by settings and levels of the health system? Aids 26Suppl 2: S97-S103.
43. Cohen RL, Li Y, Giese R, Mancuso JD (2012) An Evaluation of PEPFAR's Effect on Health Systems Strengthening in Sub-Saharan Africa. J Acquir Immune Defic Syndr.
44. Romania (2012) UNGASS Country Progress Report. UNAIDS.
45. Mongolia (2012) UNGASS Country Progress Report. UNAIDS.
46. Global Fund (2012) Approved Grant Amounts and Disbursements. Geneva, Switzerland: The Global Fund to Fight AIDS, Tuberculosis and Malaria.